US warning to Novo Nordisk over concealing suspected Ozempic side effects
The US Food and Drug Administration (FDA) has issued a warning to the Danish company Novo Nordisk. According to the FDA, Novo Nordisk concealed suspected side effects of its best-selling drug Ozempic - used to treat type 2 diabetes.
Business


